Drs. Alla Goldberg, Christopher Henry and Ashvini Reddy join for a panel discussion of uveitis and risk management, including discussions of monitoring patients on high-risk medications and poor adherence to follow-up.
Financial Disclosures: Dr. Sridhar has no relevant disclosures. Dr. Henry has consulted for Clearside and Castle and sits on the advisory board for Aldeyra, Alimera and Clearside. Dr. Reddy has consulted for Clearside. Dr. Goldberg has no financial disclosures.
CME Information
Release: May 17, 2020; expires May 17, 2023
Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD
Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.
Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.
Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.
Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.